malignant mesothelioma in effusions and fine needle aspirates
DESCRIPTION
Malignant Mesothelioma in Effusions and Fine Needle Aspirates. Armando C. Filie, M.D. National Cancer Institute. No relationship exists that represents a possible conflict of interest with respect to the content of this presentation. OBJECTIVES. Objectives - PowerPoint PPT PresentationTRANSCRIPT
Malignant Mesothelioma in Effusions and Fine
Needle Aspirates
No relationship exists that represents a possible conflict of interest with respect to the content of this presentation
Armando C. Filie, M.D.National Cancer Institute
CYTOTELECONFERENCE 2007 - 2008 2
CYTOTELECONFERENCE 2007 - 2008 3
OBJECTIVES
Objectives
• Recognize the cytological features of malignant mesothelioma (mesothelioma) in effusion samples
• Recognize the cytological features of fine needle aspirates of mesothelioma
• Recognize the cytological features of major lesions in the differential diagnosis of mesothelioma
• Familiarize with current ancillary studies in the diagnosis of mesothelioma
CYTOTELECONFERENCE 2007 - 2008 4
BLANK SLIDEMesothelioma
• Malignant neoplasm of pleura, peritoneal cavity and pericardium• Incidence of 2,500 cases/year (pleural)• Clinical Findings• age and presentation: males, 6th-8th decade, unilateral• pathogenesis: asbestos exposure (latency of 20-50 years), ?simian vacuolating virus (SV40)• imaging findings: CT scan [pleural masse(s)], invasion by magnetic resonance imaging (MRI)
• Diagnosis: clinical history + imaging findings + cytology(?)/biopsy
CYTOTELECONFERENCE 2007 - 2008 5
Mesothelioma
• Prognosis and Treatment• poor prognosis• treatment: surgery (most effective), chemotherapy, radiotherapy (localized recurrences), combine therapy
• Histologic Types• epithelioid (epithelial): up to 17 subtypes (deciduoid, clear cell, small cell, signet ring)• sarcomatoid: 8 subtypes (fibrosarcomatous, lymphohistiocytoid, MFH-like)• biphasic (mixed)• desmoplastic
CYTOTELECONFERENCE 2007 - 2008 6
Mesothelioma
• Cytological Features in Effusions• sample preparation: smear, cytocentrifugation, thin layer, cell block (immunostains)• stains: Diff-Quik, Papanicolaou
CYTOTELECONFERENCE 2007 - 2008 7
Mesothelioma
• Cytological Features in Effusions• patterns: epithelioid (malignant epithelial), sarcomatous (sarcomatoid), anaplastic, biphasic• sarcomatoid mesothelioma differential diagnosis: spindle cell sarcomas• biphasic mesothelioma differential diagnosis: carcinomas (renal cell carcinoma)• anaplastic mesothelioma differential diagnosis: pleomorphic sarcomas
• epithelioid mesothelioma: most frequent pattern, associated with effusion more frequently than other patterns.
CYTOTELECONFERENCE 2007 - 2008 8
Mesothelioma in Effusions
Cytological Features of Epithelioid Mesothelioma• cellular sample• one cell population• clusters (scalloped border)• cell-in-cell formations• intercellular spaces (“windows”)• two-tone cytoplasm• surface blebs• variable N/C ratio• multinucleation• macronucleoli
CYTOTELECONFERENCE 2007 - 2008 9
Mesothelioma in Effusions
Cytological Features of Epithelioid Mesothelioma
CYTOTELECONFERENCE 2007 - 2008 10
Mesothelioma in Effusions
Cytological Features of Epithelioid Mesothelioma
CYTOTELECONFERENCE 2007 - 2008 11
Mesothelioma in Effusions
Differential Diagnosis
• Metastatic carcinoma: adenocarcinomas (lung, breast, gynecologic tract, gastrointestinal tract), may be the first manifestation of an occult primary• Hematologic neoplasms: B-cell lymphomas (diffuse large B-cell), T-cell lymphomas (anaplastic large cell), plasma cell neoplasms, primary effusion lymphoma (PEL)• Melanoma: may be the first manifestation of disease• Others: squamous cell carcinoma, mesothelial cell lesions
CYTOTELECONFERENCE 2007 - 2008 12
Mesothelioma in Effusions
Cytological Features of Metastatic Adenocarcinoma• cellular sample• two cell population• clusters (smooth border)• cell-in-cell formations• high N/C ratio• multinucleation• macronucleoli• irregular nuclear contours• delicate/dense cytoplasm• vacuole(s) displacing the nucleus
CYTOTELECONFERENCE 2007 - 2008 13
Mesothelioma in Effusions
Cytological Features of Metastatic Adenocarcinoma
CYTOTELECONFERENCE 2007 - 2008 14
Mesothelioma in Effusions
Cytological Features of Metastatic Melanoma• cellular sample• two cell population (?)• aggregates • cell-in-cell formations• low N/C ratio• multinucleation• macronucleoli• intranuclear cytoplasmic inclusions• melanin pigment• vacuoles
CYTOTELECONFERENCE 2007 - 2008 15
Mesothelioma in Effusions
Cytological Features of Metastatic Melanoma
CYTOTELECONFERENCE 2007 - 2008 16
Mesothelioma in Effusions
Cytological Features of PEL• cellular sample• two cell population• variable N/C ratio• multinucleation• macronucleoli• dense basophilic cytoplasm
CYTOTELECONFERENCE 2007 - 2008 17
Mesothelioma in Effusions
Cytological Features of PEL
CYTOTELECONFERENCE 2007 - 2008 18
Mesothelioma in Fine Needle Aspirates
• Image-guided fine needle aspiration (FNA) may be used for the initial diagnosis of mesothelioma• 4% needle tract seeding for core-needle biopsy with sensitivity of 86% (pleural)
• FNA of metastatic mesothelioma (rare): scalp, thyroid, cervical lymph node, axillary lymph node, subcutaneous nodules, breast, liver• metastasis may be the first indication of mesothelioma• inclusions of benign mesothelial cells in lymph nodes
• Mesothelial cell lesions of pleura: solitary fibrous tumor (most benign, rare malignant), nodular pleural plaque, adenomatoid tumor, simple mesothelial cyst, multicystic mesothelioma, well-differentiated papillary mesothelioma, localized malignant mesothelioma
CYTOTELECONFERENCE 2007 - 2008 19
Mesothelioma in Fine Needle Aspirates
Cytological Features of Mesothelioma in FNAs• cellular aspirate• clusters and flat sheets• papillary groups (core)• acinar/tubular groups• single cells• intercellular spaces• round/polygonal shape• spindle cells (sarcomatoid, biphasic)• small cytoplasmic vacuoles• multinucleation
CYTOTELECONFERENCE 2007 - 2008 20
Mesothelioma in Fine Needle Aspirates
Cytological Features of Mesothelioma in FNAs
CYTOTELECONFERENCE 2007 - 2008 21
Mesothelioma in Fine Needle Aspirates
Differential Diagnosis
• Epithelioid: carcinoma - lung (adenocarcinoma and bronchoalveolar carcinoma [BAC]), ovary and peritoneal serous carcinoma; mesothelial cell lesions; thymoma; epithelioid sarcomas, reactive mesothelial proliferations• Sarcomatoid: mesothelial cell lesions, desmoid tumor, schwannoma, spindle cell sarcomas• Biphasic: thymoma, synovial sarcoma, desmoplastic small round cell tumor, pleuropulmonary blastoma• Anaplastic: pleomorphic sarcomas
CYTOTELECONFERENCE 2007 - 2008 22
Mesothelioma in Fine Needle Aspirates
Cytological Features of Lung BAC in FNAs• monolayer sheets• papillae• single cells• round nuclei• nuclear grooves and pseudoinclusions• nuclear crowding/overlapping• pleomorphic cells• mucin (mucinous)
CYTOTELECONFERENCE 2007 - 2008 23
Mesothelioma in Fine Needle Aspirates
Cytological Features of Lung BAC in FNAs
CYTOTELECONFERENCE 2007 - 2008 24
Mesothelioma (Ancillary Studies)
• Histochemical stains: mucin (Alcian blue, mucicarmin)• Electron microscopy: long microvilli (meso), short (adeno)• FISH: detection of chromosomal alterations• Hyaluronic acid levels in effusion samples• Immunocytochemistry: most commonly used• may be applied to cytocentrifuged samples, smears, thin layer samples, cell blocks (preferred)• panel of mesothelial cell and adenocarcinoma markers: 2 meso and 2 adeno markers or 1/2 meso and 3 adeno markers• other markers: hematopoietic markers, melanoma markers, site “specific” markers (TTF-1, PSA, PAP, CDX-2, GCDFP-15, thyroglobulin)
CYTOTELECONFERENCE 2007 - 2008 25
Mesothelioma (Ancillary Studies)
Mesothelial cell (Mesothelioma) Markers• calretinin: neuron-specific calcium binding protein (neural tissues and a few other cell types like mesothelial cells)• cytokeratin 5/6: intermediate filament (mainly keratinized and non-keratinized squamous cell carcinoma)• Others: HBME-1, WT1,Mesothelin, Podoplanin
calretinin
CYTOTELECONFERENCE 2007 - 2008 26
Mesothelioma (Ancillary Studies)
Mesothelial cell (Mesothelioma) Markers
HBME-1 CK 5/6
CYTOTELECONFERENCE 2007 - 2008 27
Mesothelioma (Ancillary Studies)
Adenocarcinoma Markers• B72.3: antibody detects a tumor associated protein• Ber-EP4: antibody against epithelial adhesion molecule• CA19.9: antibody against Lewisa blood group antigen• Others: mCEA, CD15, MOC-31
B72.3
CYTOTELECONFERENCE 2007 - 2008 28
Mesothelioma (Ancillary Studies)
Adenocarcinoma Markers
B72.3 Ber-EP4 CA19.9
CYTOTELECONFERENCE 2007 - 2008 29
Mesothelioma (Ancillary Studies)
• Melanoma markers: HMB45, Mart-1, KBA62, S100• Hematopoietic markers: LCA, L26, CD38, HHV8• Others: TTF-1, PSA and PAP, GCDFP-15, thyroglobulin
HMB45 Mart-1
CYTOTELECONFERENCE 2007 - 2008 30
Mesothelioma (Ancillary Studies)
Hematopoietic and other markers
HHV8 TTF-1 CK 7
CYTOTELECONFERENCE 2007 - 2008 31
Mesothelioma (Ancillary Studies)
Molecular Tests• Gene expression (quantitative RT-PCR)• Proteomics: protein complement of the genome (serum - early cancer diagnosis), potential in cytopathology• Surface enhanced laser desorption/ionization time of flight (SELDI-TOF): protein profile in cytology samples (Fetsch et al, 2002)• Initial set: 5 renal cell carcinomas, 9 metastatic melanomas, 6 reactive effusions• Unknown set: 4 renal cell carcinomas, 8 metastatic melanomas, 3 reactive effusions
CYTOTELECONFERENCE 2007 - 2008 32
Mesothelioma (Ancillary Studies)
Molecular Tests•SELDI-TOF in FNAs and fluid samples of 8 MM, 4 RCC, 3 reactive effusions
0
1
2
3
4
5
6
7
8
9
RCC Reac Meso Met Mel
Tested
+Cases
CYTOTELECONFERENCE 2007 - 2008 33
Mesothelioma in Effusions and FNAs
SUMMARY
• Cytological features of mesothelioma in effusions and FNAs overlap with those seen in other benign and malignant lesions (adenocarcinoma)
• Some cytologic features of mesothelioma are not often present in cytology samples of lesions that should be considered in the differential diagnosis
• Ancillary studies are important in supporting the diagnosis of mesothelioma (immunocytochemistry, electron microscopy)
• Diagnosis of mesothelioma has prognostic, treatment and legal implications